Does short preoperative statin therapy prevent infectious complications in adults undergoing cardiac or non-cardiac surgery?

References

1. ↵
   1. Hao PP,
   2. Chen YG,
   3. Wang JL,
   4. Ji WQ,
   5. Xue L,
   6. Liu XH,
   7. et al.

   (2010) Meta-analysis of the role of high-dose statins administered prior to percutaneous coronary intervention in reducing major adverse cardiac events in patients with coronary artery disease. Clin Exp Pharmacol Physiol 37:496–500.

   OpenUrlCrossRefPubMed
2. 1. Das S,
   2. Nanda SK,
   3. Bisoi AK,
   4. Wadhawan AN

   (2016) Effect of preoperative statin therapy on early postoperative memory impairment after off-pump coronary artery bypass surgery. Ann Card Anaesth 19:38–44.

   OpenUrl
3. 1. Berwanger O,
   2. Le Manach Y,
   3. Suzumura EA,
   4. Biccard B,
   5. Srinathan SK,
   6. Szczeklik W,
   7. et al.

   (2016) Association between pre-operative statin use and major cardiovascular complications among patients undergoing non-cardiac surgery: the VISION study. Eur Heart J 37:177–185.

   OpenUrlCrossRefPubMed
4. 1. Youn YN,
   2. Park SY,
   3. Hwang Y,
   4. Joo HC,
   5. Yoo KJ

   (2011) Impact of high-dose statin pretreatment in patients with stable angina during off-pump coronary artery bypass. Korean J Thorac Cardiovasc Surg 44:208–214.

   OpenUrlPubMed
5. ↵
   1. Sanders RD,
   2. Nicholson A,
   3. Lewis SR,
   4. Smith AF,
   5. Alderson P

   (2013) Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery. Cochrane Database Syst Rev 7:CD009971.

   OpenUrlPubMed
6. ↵
   1. Dong L,
   2. Zhang F,
   3. Shu X

   (2011) Usefulness of statins pretreatment for the prevention of postoperative atrial fibrillation in patients undergoing cardiac surgery. Ann Med 43:69–74.

   OpenUrlCrossRefPubMed
7. ↵
   1. van den Hoek HL,
   2. Bos WJ,
   3. de Boer A,
   4. van de Garde EM

   (2011) Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trials. BMJ 343:d7281.

   OpenUrlAbstract/FREE Full Text
8. ↵
   1. Trezzi M,
   2. Blackstone EH,
   3. Sun Z,
   4. Li L,
   5. Sabik JF 3rd.,
   6. Lytle BW,
   7. et al.

   (2013) Statin therapy is associated with fewer infections after cardiac operations. Ann Thorac Surg 95:892–900.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   1. Hartholt NL,
   2. Rettig TC,
   3. Schijffelen M,
   4. Morshuis WJ,
   5. van de Garde EM,
   6. Noordzij PG

   (2014) Preoperative statin therapy and infectious complications in cardiac surgery. Neth Heart J 22:503–509.

   OpenUrlCrossRefPubMed
10. ↵
    1. Tleyjeh IM,
    2. Alasmari FA,
    3. Bin Abdulhak AA,
    4. Riaz M,
    5. Garbati MA,
    6. Erwin PJ,
    7. et al.

    (2012) Association between preoperative statin therapy and postoperative infectious complications in patients undergoing cardiac surgery: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 33:1143–1151.

    OpenUrlCrossRefPubMed
11. ↵
    1. Iannuzzi JC,
    2. Rickles AS,
    3. Kelly KN,
    4. Rusheen AE,
    5. Dolan JG,
    6. Noyes K,
    7. et al.

    (2014) Perioperative pleiotropic statin effects in general surgery. Surgery 155:398–407.

    OpenUrlCrossRefPubMed
12. ↵
    1. Bao-Xin Ma,
    2. Hua Li,
    3. Jing-Sen Li,
    4. Sui-Sheng Wu

    (2015) Effect of statins on preventing infectious complications after surgery: Systematic review and meta-analysis. J Int Med Res 43:610–618.

    OpenUrlCrossRefPubMed
13. ↵
    1. Jadad AR,
    2. Moore RA,
    3. Carroll D,
    4. Jenkinson C,
    5. Reynolds DJ,
    6. Gavaghan DJ,
    7. et al.

    (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12.

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    1. Spadaccio C,
    2. Pollari F,
    3. Casacalenda A,
    4. Alfano G,
    5. Genovese J,
    6. Covino E,
    7. et al.

    (2010) Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. J Cardiovasc Pharmacol 55:30–38.

    OpenUrlCrossRefPubMed
15. 1. Chello M,
    2. Patti G,
    3. Candura D,
    4. Mastrobuoni S,
    5. Di Sciascio G,
    6. Agro F,
    7. et al.

    (2006) Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med 34:660–667.

    OpenUrlCrossRefPubMedWeb of Science
16. ↵
    1. Vukovic PM,
    2. Maravic-Stojkovic VR,
    3. Peric MS,
    4. Jovic M,
    5. Cirkovic MV,
    6. Gradinac S,
    7. et al.

    (2011) Steroids and statins: an old and a new anti-inflammatory strategy compared. Perfusion 26:31–37.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    1. Dunkelgrun M,
    2. Boersma E,
    3. Schouten O,
    4. Koopman-van Gemert AW,
    5. van Poorten F,
    6. Bax JJ,
    7. et al.

    (2009) Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV). Ann Surg 249:921–926.

    OpenUrlCrossRefPubMedWeb of Science
18. ↵
    1. Shokouhi S,
    2. Alavi Darazam I,
    3. Sharifi G,
    4. Gachkar L,
    5. Amirsardari A,
    6. Samadian M

    (2014) Statins and postoperative infections: a randomized clinical trial. Jundishapur J Microbiol 7:e9456.

    OpenUrl
19. ↵
    1. Abela GS,
    2. Vedre A,
    3. Janoudi A,
    4. Huang R,
    5. Durga S,
    6. Tamhane U

    (2011) Effect of statins on cholesterol crystallization and atherosclerotic plaque stabilization. Am J Cardiol 107:1710–1717.

    OpenUrlCrossRefPubMed
20. 1. Yaktubay Dondas N,
    2. Sucu N,
    3. Coskun Yilmaz B,
    4. Kaplan HM,
    5. Ozeren M,
    6. Karaca MK,
    7. et al.

    (2011) Molecular mechanism of vasorelaxant and antiatherogenic effects of the statins in the human saphenous vein graft. Eur J Pharmacol 666:150–157.

    OpenUrlPubMed
21. 1. Gismondi RA,
    2. Bedirian R,
    3. Pozzobon CR,
    4. Ladeira MC,
    5. Oigman W,
    6. Neves MF

    (2015) Renin-angiotensin system blockade associated with statin improves endothelial function in diabetics. Arq Bras Cardiol 105:597–605.

    OpenUrl
22. ↵
    1. Li DW,
    2. Li JH,
    3. Wang YD,
    4. Li GR

    (2015) Atorvastatin protects endothelial colony forming cells against H2O2 induced oxidative damage by regulating the expression of annexin A2. Mol Med Rep 12:7941–7948.

    OpenUrl
23. ↵
    1. Kuhn EW,
    2. Liakopoulos OJ,
    3. Stange S,
    4. Deppe AC,
    5. Slottosch I,
    6. Choi YH,
    7. et al.

    (2014) Preoperative statin therapy in cardiac surgery: a meta-analysis of 90,000 patients. Eur J Cardiothorac Surg 45:17–26, discussion 26.

    OpenUrlCrossRefPubMed
24. 1. Zhang F,
    2. Dong L,
    3. Ge J

    (2010) Effect of statins pretreatment on periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: a meta-analysis. Ann Med 42:171–177.

    OpenUrlCrossRefPubMed
25. ↵
    1. Chen WT,
    2. Krishnan GM,
    3. Sood N,
    4. Kluger J,
    5. Coleman CI

    (2010) Effect of statins on atrial fibrillation after cardiac surgery: a duration- and dose-response meta-analysis. J Thorac Cardiovasc Surg 140:364–372.

    OpenUrlCrossRefPubMedWeb of Science
26. ↵
    1. Rattazzi M,
    2. Faggin E,
    3. Buso R,
    4. Di Virgilio R,
    5. Puato M,
    6. Plebani M,
    7. et al.

    (2016) Atorvastatin reduces circulating osteoprogenitor cells and T-cell RANKL expression in osteoporotic women: Implications for the bone-vascular axis. Cardiovasc Ther 34:13–20.

    OpenUrlCrossRefPubMed
27. ↵
    1. Biasucci LM,
    2. Biasillo G,
    3. Stefanelli A

    (2010) Inflammatory markers, cholesterol and statins: pathophysiological role and clinical importance. Clin Chem Lab Med 48:1685–1691.

    OpenUrlCrossRefPubMed
28. ↵
    1. Nie P,
    2. Li D,
    3. Hu L,
    4. Jin S,
    5. Yu Y,
    6. Cai Z,
    7. et al.

    (2014) Atorvastatin improves plaque stability in ApoE-knockout mice by regulating chemokines and chemokine receptors. PLoS One 9:e97009.

    OpenUrlCrossRefPubMed
29. ↵
    1. López-Cortés LE,
    2. Gálvez-Acebal J,
    3. Del Toro MD,
    4. Velasco C,
    5. de Cueto M,
    6. Caballero FJ,
    7. et al.

    (2013) Effect of statin therapy in the outcome of bloodstream infections due to Staphylococcus aureus: a prospective cohort study. PLoS One 8:e82958.

    OpenUrlCrossRefPubMed
30. ↵
    1. Butt AA,
    2. Yan P,
    3. Bonilla H,
    4. Abou-Samra AB,
    5. Shaikh OS,
    6. Simon TG,
    7. et al.

    (2015) Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES. Hepatology 62:365–374.

    OpenUrlCrossRefPubMed
31. ↵
    1. Emani S,
    2. Gunjiganur GV,
    3. Mehta DS

    (2014) Determination of the antibacterial activity of simvastatin against periodontal pathogens, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans: An in vitro study. Contemp Clin Dent 5:377–382.

    OpenUrl
32. ↵
    1. Lobato LS,
    2. Rosa PS,
    3. Ferreira Jda S,
    4. Neumann Ada S,
    5. da Silva MG,
    6. do Nascimento DC,
    7. et al.

    (2014) Statins increase rifampin mycobactericidal effect. Antimicrob Agents Chemother 58:5766–5774.

    OpenUrlAbstract/FREE Full Text